Targeting ABL and SRC kinases in chronic myeloid leukemia: Experience with dasatinib

Alfonso Quintás-Cardama, Hagop Kantarjian, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'Targeting ABL and SRC kinases in chronic myeloid leukemia: Experience with dasatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences